In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 4, 2003, Pages 1407-1409

  Crowell, Andrea L ^a   Sanders Lewis, Kolby A ^a,b   Secor, W Evan ^a,c  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; TINIDAZOLE;

ARTICLE; DRUG EFFECT; HUMAN; IN VITRO STUDY; INFECTION RISK; LETHALITY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTOZOAL INFECTION; SEXUALLY TRANSMITTED DISEASE; STRAIN DIFFERENCE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS;

ANIMALS; DRUG RESISTANCE; FEMALE; HUMANS; METRONIDAZOLE; TINIDAZOLE; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS;

EID: 0037378741     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.4.1407-1409.2003     Document Type: Article

References (23)

1. Bowden, F. J., and G. P. Garnett. 1999. Why is Trichomonas vaginalis ignored? Sex. Transm. Infect. 75:372-374.
2. Cates, W., Jr. 1999. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex. Transm. Dis. 26(Suppl.):S2-S7.
3. Centers for Disease Control and Prevention. 1993. Sexually transmitted diseases treatment guidelines. Morb. Mortal. Wkly. Rep. 42(RR-14):70-72.
4. Cotch, M. F., J. G. Pastorek II, R. P. Nugent, S. L. Hillier, R. S. Gibbs, D. H. Martin, D. A. Eschenbach, R. Edelman, J. C. Carey, J. A. Regan, M. A. Krohn, M. A. Klebanoff, A. V. Rao, and G. G. Rhoads. 1997. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex. Transm. Dis. 24:353-360.
5. Durel, P., V. Roiron, A. Siboulet, and L. J. Borel. 1960. Systemic treatment of human trichomoniasis with a derivative of nitroimidazole 8823 R.P. Br. J. Vener. Dis. 36:21-26.
6. Gulmezoglu, A. M., and P. Garner. 1998. Trichomoniasis treatment in women: a systematic review. Trop. Med. Int. Health 3:553-558.
7. Hobbs, M. M., P. Kazembe, A. W. Reed, W. C. Miller, E. Nakata, D. Zimba, C. C. Daly, H. Chakraborty, M. Cohen, and I. Hoffman. 1999. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex. Transm. Dis. 26:381-387.
8. Hook, E. W., III. 1999. Trichomonas vaginalis - no longer a minor STD. Sex. Transm. Dis. 26:388-389.
9. Krieger, J. N. 2000. Consider diagnosis and treatment of trichomoniasis in men. Sex. Transm. Dis. 27:241-242.
10. Kurohara, M. L., F. K. Kwong, T. B. Lebherz, and W. B. Klaustermeyer. 1991. Metronidazole hypersensitivity and oral desensitization. J. Allergy Clin. Immunol. 88:279-280.
11. Lossick, J. G., M. Muller, and T. E. Gorrell. 1986. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J. Infect. Dis. 153:948-955.
12. Meingassner, J. G., and J. Thurner. 1979. Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles. Antimicrob. Agents Chemother. 15:254-257.
13. Muller, M., J. G. Lossick, and T. E. Gorrell. 1988. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex. Transm. Dis. 15:17-24.
14. Narcisi, E. M., and W. E. Secor. 1996 . In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Antimicrob. Agents Chemother. 40:1121-1125.
15. Petrin, D., K. Delgaty, R. Bhatt, and G. Garber. 1998. Clinical and microbiological aspects of Trichomonas vaginalis. Clin. Microbiol. Rev. 11:300-317.
16. Quan, M. 2000. Vaginitis, meeting the clinical challenge. Clin. Cornerstone 3:36-47.
17. Rasoloson, D., S. Vanacova, E. Tomkova, J. Razga, I. Hrdy, J. Tachezy, and J. Kulda. 2002. Mechanisms of in vitro development of resistance to metronidazole in Trichomonas vaginalis. Microbiology 148:2467-2477.
18. Robinson, S. C. 1962, Trichomonal vaginitis resistant to metronidazole. Can. Med. Assoc. J. 86:665.
19. Smilack, J. D., W. R. Wilson, and F. R. Cockerill III. 1991. Tetracyclines, chloramphenicol, erythromycin, clindamycin, and metronidazole. Mayo Clin. Proc. 66:1270-1280.
20. Sobel, J. D., P. Nyirjesy, and W. Brown. 2001. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin. Infect. Dis. 33:1341-1346.
21. Sorvillo, F., and P. Kerndt. 1998. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet 351:213-214.
22. Sorvillo, F., A. Kovacs, P. Kerndt, A. Stek, L. Muderspach, and L. Sanchez-Keeland. 1998. Risk factors for trichomoniasis among women with human immunodeficiency virus (HIV) infection at a public clinic in Los Angeles County, California: implications for HIV prevention. Am. J. Trop. Med. Hyg. 58:495-500.
23. World Health Organization. 1995. An overview of selected curable sexually transmitted diseases, p. 2-27. In Global program on AIDS. World Health Organization, Geneva, Switzerland.